An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis

Eur J Clin Pharmacol. 2018 Mar;74(3):267-274. doi: 10.1007/s00228-017-2389-x. Epub 2017 Dec 2.

Abstract

Introduction: Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of this study was to clarify which of four different low-dose anticoagulant modes was preferable in reducing the exposure to i.v. unfractionated heparin (heparin) and maintaining patency of the dialysis circuit.

Methods: Twenty-three patients on SHD were included to perform haemodialysis with four modes of low-dose anticoagulation. For comparative analyses, patients served as their own control. Haemodialysis with a single bolus of tinzaparin at the start was compared to haemodialysis initiated without i.v. heparin but priming with (1) heparin in saline (H), (2) heparin and albumin in saline (HA), (3) heparin and albumin in combination with a citrate-containing dialysate (HAC), (4) saline and usinga heparin-coated filters (Evodial®). The priming fluid was discarded before dialysis started. Blood samples were collected at 0, 30 and 180 min during haemodialysis. Smaller bolus doses of heparin (500 Units/dose) were allowed during the modes to avoid interruption by clotting.

Findings: The mean activated partial thromboplastin (APTT) time as well as the doses of anticoagulation administered was highest with SHD and least with HAC and Evodial®. Mode H versus SHD had the highest rate of prematurely interrupted dialyses (33%, p = 0.008). The urea reduction rate was less with Evodial® vs. SHD (p < 0.01). One hypersensitivity reaction occurred with Evodial®. Changes in blood cell concentrations and triglycerides differed between the modes.

Discussion: If intermittent haemodialysis is necessary in patients at risk of bleeding, anticoagulation using HAC and Evodial® appeared most preferable with least administration of heparin, lowest APTT increase and lowest risk for prematurely clotted dialyzers in contrast to the least plausible H mode.

Keywords: Anticoagulation; Haemodialysis; Haemorrhage; Priming.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / chemistry
  • Anticoagulants / pharmacology*
  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects*
  • Case-Control Studies
  • Citric Acid / adverse effects
  • Citric Acid / pharmacology
  • Drug Liberation
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control*
  • Heparin / adverse effects
  • Heparin / chemistry
  • Heparin / pharmacology
  • Heparin / therapeutic use
  • Hospitals, University
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy*
  • Kinetics
  • Male
  • Micropore Filters / adverse effects
  • Middle Aged
  • Partial Thromboplastin Time
  • Renal Dialysis / adverse effects*
  • Risk
  • Serum Albumin, Human / administration & dosage
  • Serum Albumin, Human / adverse effects
  • Solubility
  • Sweden / epidemiology
  • Thrombosis / epidemiology
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Urea / blood

Substances

  • Anticoagulants
  • Citric Acid
  • Urea
  • Heparin
  • Serum Albumin, Human